AI assistant
SCHOOLBLAZER LIMITED — Capital/Financing Update 2022
Sep 18, 2022
65751_rns_2022-09-18_9d5a6b51-8d08-4081-ad95-b07a22413432.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [196 x 58] intentionally omitted <==
ASX ANNOUNCEMENT
DIVESTMENT COMPLETION
19[th] September 2022
Company Announcements Office Australian Securities Exchange Authorised by the Board for immediate release
PEGASUS DIVESTMENT
Further to the announcements of August 10, 2022 and September 15, 2022, Hancock and Gore (H&G) is pleased to advise that completion for the divestment of its 70% interest in Pegasus Healthcare Group (Pegasus) has now occurred.
For more information, please contact Executive Chair, Sandy Beard on 0412 308 263
ABOUT H&G
H&G is a diversified investment company with a focus on active management and driving shareholder returns through investing in a broad range of opportunities across private equity, ASX listed equities, funds management, real property, debt funding and other alternative investments. We seek to become a trusted partner of choice that aims to solve our partners’ problems, identifying and pursuing opportunities that benefit all parties.
HANCOCK AND GORE LIMITED ACN 009 657 961 I ASX:HNG Suite 803, 25 Bligh Street, Sydney NSW 2000 AUSTRALIA www.hancockandgore.com.au